Literature DB >> 14971873

Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.

H Y Jin1, K S Lee, S M Jin, Y C Lee.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent, multifunctional cytokine that contributes to angiogenesis and inflammation. Matrix metalloproteinase-9 (MMP-9) is one of the major proteolytic enzymes that degrade various components of the extracellular matrix. Few data are available on the potential relationship between VEGF and MMP-9 in the accumulation of pleural effusion. We examined levels of VEGF and MMP-9 by means of enzyme immunoassay, zymographic analysis, and Western blot analysis in the patients with liver cirrhosis, tuberculosis, or lung cancer. The levels of VEGF and MMP-9 were significantly increased in the pleural fluids and sera of patients with tuberculosis and were even higher in patients with lung cancer compared with the patients with liver cirrhosis. A significant correlation was established between the level of VEGF and the level of MMP-9 in the pleural effusion. These results suggest that overproduction of VEGF and MMP-9 is associated with accumulation of the pleural effusion in tuberculosis and lung cancer. The relationship between VEGF and MMP-9 in the pleural effusion may have a role in the pathogenesis of pleural fluid formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971873     DOI: 10.1016/j.rmed.2003.09.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.

Authors:  Yong-Chun Shen; Meng-Qi Liu; Chun Wan; Lei Chen; Tao Wang; Fu-Qiang Wen
Journal:  Exp Ther Med       Date:  2012-03-14       Impact factor: 2.447

2.  Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Jessica M Hattle; Steven A Dreitz; JoLynn M Troudt; Linda S Izzo; Randall J Basaraba; Ian M Orme; Lynn M Matrisian; Angelo A Izzo
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

3.  Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

4.  Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.

Authors:  Stacey D Finley; Aleksander S Popel
Journal:  J Natl Cancer Inst       Date:  2013-05-13       Impact factor: 13.506

5.  The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.

Authors:  Alfonso Fiorelli; Floriana Morgillo; Morena Fasano; Giovanni Vicidomini; Vincenzo Giuseppe Di Crescenzo; Marina Di Domenico; Marina Accardo; Mario Santini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-28

6.  Increased fibrosis and interstitial fluid pressure in two different types of syngeneic murine carcinoma grown in integrin β3-subunit deficient mice.

Authors:  Tomas Friman; Renata Gustafsson; Linda B Stuhr; Jean Chidiac; Nils-Erik Heldin; Rolf K Reed; Ake Oldberg; Kristofer Rubin
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

7.  An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition.

Authors:  Amartya Mishra; Parthasarathi Bhattacharya; Sumit Paul; Rantu Paul; Snehasikta Swarnakar
Journal:  Lung India       Date:  2011-07

Review 8.  Systematic review and meta-analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions.

Authors:  Eleftheria Fafliora; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Physiol Rep       Date:  2016-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.